Guidant (GDT ) sees Q4 revenues coming in below analysts' expectations, with an impact on EPS of $0.02-$0.03 per share.
Lehman cut its 2001 estimate and reiterated its neutral rating on Minnesota Mining & Manufacturing (MMM ).
Brooktrout (BRKT ) sees lower than expected $0.03-$0.05 Q4 EPS on $33M-$33.5M in revenues. The company cites a slowdown in the telecom market.
CV Therapeutics (CVTX ) says it plans to enroll 186 more patients in Phase III Ranolazine trials. SG Cowen says this is a six-month delay, but sees no fundamental consequence to the trial.
A California judge rules key part of technology used by Applera Corp-Applied Biosystems ( ABI ) and Applera Corp-Celera Genomics (CRA ) to sequence human genome infringes NYCOMED AMERSHAM's patent.
PC-Tel Inc. (PCTI ) forecast a $0.07-$0.10 per share Q4 loss (pro forma) on $16.5 to $17.5 million in revenues as a result of rapid deterioration in PC demand.
Keynote (KEYN ) sees lower than expected $13M-$13.2M Q1 revenues, but expects to meet $0.11 First Call EPS consensus.
Merrill Lynch downgraded Biogen Inc. (BGEN ) to near, long term accumulate from buy.
According to Dataquest, Nokia (NOK ) extended its global market share lead in Q3 to above 30%.
Nordstrom, Inc. (JWN ) sees $0.18-$0.23 Q4 EPS vs. the consensus of $0.38 due to weak sales and increased markdown activity. The company also posted a 2.9% December same store sales decline and a 5.6% total sales rise.
Morgan Stanley DW downgraded Capital One (COF ) shares to neutral.
PPL Corp. (PPL ) says that even if it is unable to collect the amount it is owed for energy sales to California, it still expects to exceed Wall Street's $3.03 2000 EPS consensus estimate.
99 Cents Only (NDN ) posted slightly lower Q4 same-store sales. The company plans to grow EPS at 20% per year and grow its store base by 25% in 2001.
Next Level (NXTV ) sees a $0.22 Q4 loss per share on $31 million in revenues. The company cites reduced revenue from Qwest and slower than anticipated customer development in Korea.
Bausch & Lomb (BOL ) sees $0.69-$0.71 Q4 EPS from operations on about $460M in revenues. Sales were modestly lower than expected due to a weaker U.S. refractive surgery business.
Backweb Tech (BWEB ) sees a $0.11-$0.14 Q4 loss per share on $7.1M-$7.4M in revenue. Backweb cites a recent slowdown in IT-related spending among Global 2000 companies.
MONY Group (MNY ) sees up to $0.10 shortfall from $0.51 Q4 EPS plan due to the decline in equity markets. MONY sees operating EPS reduced by an additional $0.30-$0.35 due to mark-to-market losses in its equity partnership venture capital portfolio.
Copper Mountain (CMTN ) sees $46M-$49M Q4 revenue, and notes an adverse impact from continuing weakness in its competitive local exchange carrier customer base -- and its decision not to recognize as revenue $8M of equipment shipped in Q4.
eBenX (EBNX ) is comfortable with Q4 consensus revenue and EPS estimates. But the company sees results in the 2001 first half impacted by a lower enrollment commitment number.
Starbucks (SBUX ) posted 8% higher December comparable-store sales and 24% higher consolidated net revenues.
American Tower (AMT ) sees lower than expected $56M-$60M Q4 EBITDA (earnings before interest, taxes, depreciation and amortization) due to a one-time reserve for bad debt of up to $7M. The company sees better than expected $226M-$233M Q4 revenues.
Autonomy (AUTN ) says it has not seen a slowdown in overall revenue growth in Q4 of 2000, and has seen strong growth from Q3.